XOMA (XOMA) Royalty Corporation announced its Chief Financial Officer, Thomas Burns, will be stepping down from his position with XOMA Royalty to pursue other professional opportunities. In conjunction with this leadership transition, XOMA Royalty has appointed Jeffrey Trigilio as Chief Financial Officer. Most recently, Trigilio served as the Chief Financial and Operating Officer of Obsidian Therapeutics
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XOMA:
- XOMA Highlights Royalty Growth Strategy in Updated Presentation
- H.C. Wainwright remains bullish on Xoma following creative Takeda deal
- XOMA: Expanding Royalty Portfolio and Capital-Efficient Partnerships Underpin Buy Rating
- Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
- Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation